Priorities 2022-2023

ASCIA's purpose is to advance the science and practice of allergy and clinical immunology.

This is achieved by promoting the highest standard of medical practice, training, education and research, to improve the quality of life and health of people with immune system disorders, including allergies, immunodeficiencies and other immune diseases.

ASCIA works towards achieving its purpose by undertaking a wide range of initiatives that are prioritised to maximise benefits to ASCIA members.  ASCIA priorities for 2022-2023 are listed below.



  • ASCIA Annual Conference – This is the main event for allergy and immunology continuing professional development (CPD) in Australia and New Zealand, which also enables important interactions with colleagues. ASCIA members receive discounted registration fees.
  • ASCIA committees and working parties - These play a vital role within ASCIA. Membership is restricted to ASCIA members and participation is on a voluntary basis. Chairs of ASCIA committees are represented on ASCIA Council.
  • ASCIA educational dinner meetings – Only ASCIA members are eligible to attend ASCIA educational dinner meetings, which contribute to CPD and enable interactions with colleagues.
  • ASCIA online meetings ASCIA Associate members (Advanced TraineesNurses and Dietitians) and TAPID members regularly meet by videoconference, which is facilitated by ASCIA and contributes to CPD. 
  • ASCIA advanced training meetings – Only ASCIA Associate (Trainee) members are eligible to attend ASCIA advanced training meetings, which are usually held each year.

The Medical Board of Australia and the Medical Council of New Zealand have strengthened recertification requirements for medical practitioners, who will each need a CPD Home from January 2023:

  • RACP Fellows can access Information about the RACP MyCPD program here
  • RACGP Fellows can access information about  the RACGP CPD program here.
  • Rural and remote medical practitioners can access information from ACCRM here.  


  • National Allergy Council – This partnership between ASCIA and Allergy & Anaphylaxis implements the National Allergy Strategy by advocating and developing resources that include Nip allergies in the Bub and Allergy 250K.
  • ASCIA Immunodeficiency Strategy – This collaboration between ASCIA, patient support organisations and other stakeholders aims to improve the health and well-being of people with immunodeficiencies. Implementation of the Strategy commenced in 2022, with an initial focus on newborn screening for severe combined immunodeficiency (SCID).
  • Collaborations with research groups – ASCIA collaborates with more than 30 other organisations, including research groups such as the Centre for Food & Allergy Research (CFAR) and the National Allergy Centre of Excellence (NACE). 

ASCIA Priorities 2022-3

pdfASCIA Priorities 2022-202390.86 KB

Content updated May 2023 

Mod ASCIA Member
Donate to AIFA
go to NAC website

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links


ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia